These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1382440)

  • 21. Characterization of the multiple forms of mast cell degranulating peptide by NMR spectroscopy.
    Steinmetz WE; Bianco TI; Zollinger M; Pesiri D
    Pept Res; 1994; 7(2):77-82. PubMed ID: 8012124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels.
    Rehm H; Bidard JN; Schweitz H; Lazdunski M
    Biochemistry; 1988 Mar; 27(6):1827-32. PubMed ID: 2454131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide leucine arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin of the Northern Leopard frog, Rana pipiens.
    Salmon AL; Cross LJ; Irvine AE; Lappin TR; Dathe M; Krause G; Canning P; Thim L; Beyermann M; Rothemund S; Bienert M; Shaw C
    J Biol Chem; 2001 Mar; 276(13):10145-52. PubMed ID: 11099505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic peptides in bee venom, III. Synthesis of peptide fragments from the sequence of the mast-cell-degranulating peptide (author's transl)].
    Hartter P
    Hoppe Seylers Z Physiol Chem; 1977 Mar; 358(3):331-7. PubMed ID: 856709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell degranulating (MCD) peptide and its optical isomer activate GTP binding protein in rat mast cells.
    Fujimoto I; Ikenaka K; Kondo T; Aimoto S; Kuno M; Mikoshiba K
    FEBS Lett; 1991 Aug; 287(1-2):15-8. PubMed ID: 1908786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine release induced by dendroaspis natriuretic peptide from rat mast cells.
    Chai OH; Kim EK; Lee YH; Kim JG; Baik BJ; Lee MS; Han EH; Kim HT; Song CH
    Peptides; 2001 Sep; 22(9):1421-6. PubMed ID: 11514023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term enhancement of synaptic transmission by synthetic mast cell degranulating peptide and its localization of binding sites in hippocampus.
    Kondo T; Ikenaka K; Kato H; Ito K; Aimoto S; Hojo H; Mikoshiba K
    Neurosci Res; 1990 Jul; 8(3):147-57. PubMed ID: 2170876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lysine residue at 7th position of wasp chemotactic peptides.
    Nagashima K; Koike M; Saito K; Yasuhara T; Tsukamoto Y; Mori M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1990 Apr; 168(2):844-9. PubMed ID: 2159301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship of mastoparan analogs: Effects of the number and positioning of Lys residues on secondary structure, interaction with membrane-mimetic systems and biological activity.
    Souza BM; Cabrera MP; Gomes PC; Dias NB; Stabeli RG; Leite NB; Neto JR; Palma MS
    Peptides; 2015 Oct; 72():164-74. PubMed ID: 25944744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine releasing and anti-inflammatory activities of MCD-peptide and its modified forms.
    Gushchin IS; Miroshnikov AI; Martynov VI; Sviridov VV
    Agents Actions; 1981 Apr; 11(1-2):69-71. PubMed ID: 6166170
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct activation of GTP-binding proteins by venom peptides that contain cationic clusters within their alpha-helical structures.
    Tomita U; Takahashi K; Ikenaka K; Kondo T; Fujimoto I; Aimoto S; Mikoshiba K; Ui M; Katada T
    Biochem Biophys Res Commun; 1991 Jul; 178(1):400-6. PubMed ID: 1906273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide Inhibitor.
    Morissette P; Li N; Ballard JE; Vavrek M; Adams GL; Regan C; Regan H; Lee KJ; Wang W; Burton A; Chen F; Gerenser P; Li Y; Kraus RL; Tellers D; Palani A; Zhu Y; Sun C; Bianchi E; Colarusso S; De Simone D; Frattarelli T; Pasquini NM; Amin RP
    Toxicol Sci; 2022 Jan; 185(2):170-183. PubMed ID: 34897513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natriuretic peptide (ovCNP-39) from platypus (Ornithorhynchus anatinus) venom relaxes the isolated rat uterus and promotes oedema and mast cell histamine release.
    de Plater GM; Martin RL; Milburn PJ
    Toxicon; 1998 Jun; 36(6):847-57. PubMed ID: 9663691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of P401 (mast cell degranulating peptide) in solution.
    Kumar NV; Wemmer DE; Kallenbach NR
    Biophys Chem; 1988 Aug; 31(1-2):113-9. PubMed ID: 3233281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides.
    Shefler I; Zavaro O; Raz T; Baram D; Sagi-Eisenberg R
    Int Arch Allergy Immunol; 2008; 145(2):131-40. PubMed ID: 17848806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of histamine release from human skin mast cells by bradykinin analogs.
    Lawrence ID; Warner JA; Cohan VL; Lichtenstein LM; Kagey-Sobotka A; Vavrek RJ; Stewart JM; Proud D
    Biochem Pharmacol; 1989 Jan; 38(2):227-33. PubMed ID: 2464345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superoxide production in human neutrophils is enhanced by treatment with transmembrane peptides derived from human formyl peptide receptor.
    Hayashi R; Osada S; Yoshiki M; Sugiyama D; Fujita I; Hamasaki Y; Kodama H
    J Biochem; 2006 Jun; 139(6):981-8. PubMed ID: 16788048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptide.
    Kondo T; Ikenaka K; Fujimoto I; Aimoto S; Kato H; Ito K; Taguchi T; Morita T; Kasai M; Mikoshiba K
    Neurosci Res; 1992 Apr; 13(3):207-16. PubMed ID: 1376885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide.
    Cherubini E; Ben Ari Y; Gho M; Bidard JN; Lazdunski M
    Nature; 1987 Jul 2-8; 328(6125):70-3. PubMed ID: 2885754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of the neurotensin8-13 analogs Asp13-NT8-13 and Asp12-NT8-13 on mast cell secretion.
    Miller LA; Cochrane DE; Carraway RE; Feldberg RS
    Agents Actions; 1993 Jan; 38(1-2):1-7. PubMed ID: 7683173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.